Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5264_Библиотеки_им_академика_М_И_Перельмана.pdf
254
Plant-based Foods and their Implications in Brain Health
6. Lima, A. A., Mridha, M. F., Das, S. C., Kabir, M. M., Islam, M. R., & Watanobe, Y. (2022). A com-
Biology,
11(3), 469.
7. Chen, X., & Pan, W. (2014). The treatment strategies for neurodegenerative diseases by integrative
medicine. Integrative Medicine International, 1(4), 223– 225.
8. Jabir, N. R., Khan, F. R., & Tabrez, S. (2018). Cholinesterase targeting by polyphenols: A thera-
peutic approach for the treatment of Alzheimer’s disease. CNS Neuroscience & Therapeutics, 24(9),
753– 762.
9. Lin, S. X., Curtis, M. A., & Sperry, J. (2020). Pyridine alkaloids with activity in the central nervous
system. Bioorganic & Medicinal Chemistry, 28(24), 115820.
10. Winkler, A. S. (2020). The growing burden of neurological disorders in low- income and middle-
income countries: Priorities for policy making. The Lancet Neurology, 19(3), 200– 202.
11. Feigin, V. L., Nichols, E., Alam, T., Bannick, M. S., Beghi, E., Blake, N., & Fischer, F. (2019).
Global, regional, and national burden of neurological disorders, 1990– 2016: A systematic analysis
for the Global Burden of Disease Study 2016. The Lancet Neurology, 18(5), 459- 480.
12. Kruk, M. E., Gage, A. D., Arsenault, C., Jordan, K., Leslie, H. H., Roder- DeWan, S., & Pate, M.
(2018). High- quality health systems in the Sustainable Development Goals era: Time for a revolu-
tion. The Lancet Global Health, 6(11), e1196– e1252.
13. Durães, F., Pinto, M., & Sousa, E. (2018). Old drugs as new treatments for neurodegenerative
diseases. Pharmaceuticals, 11(2), 44.
14. Center, B. P. (2014). Drug- induced neurologic conditions. US Pharm, 39(1), 47– 51.
15. Duma, S. R., & Fung, V. S. (2019). Drug- induced movement disorders. Australian Prescriber,
42(2), 56.
16. Han, S., Kim, S., Kim, H., Shin, H. W., Na, K. S., & Suh, H. S. (2019). Prevalence and incidence of
Parkinson’s disease and drug- induced parkinsonism in Korea. BMC Public Health, 19(1), 1– 9.
17. Ghasemiyeh, P., Borhani- Haghighi, A., Karimzadeh, I., Mohammadi- Samani, S., Vazin, A., Safari,
A., & Qureshi, A. I. (2020). Major neurologic adverse drug reactions, potential drug- drug interactions
and pharmacokinetic aspects of drugs used in covid- 19 patients with stroke: A narrative review.
Therapeutics and Clinical Risk Management, 16, 595.
18. Champagne- Jorgensen, K., Kunze, W. A., Forsythe, P., Bienenstock, J., & Neufeld, K. A. M. (2019).
Antibiotics and the nervous system: More than just the microbes? Brain, Behavior, and Immunity,
77, 7– 15.
19. Velmurugan, B. K., Rathinasamy, B., Lohanathan, B. P., Thiyagarajan, V., & Weng, C. F. (2018).
Neuroprotective role of phytochemicals. Molecules, 23(10), 2485.
20. Prabhakar, P., & Mamoni, B. (2021). Technical problems, regulatory and market challenges in bringing
herbal drug into mainstream of modern medicinal practices. Research Journal of Biotechnology, 16
(3): 212– 222.
21. Ekor, M. (2014). The growing use of herbal medicines: issues relating to adverse reactions and
challenges in monitoring safety. Frontiers in Pharmacology, 4, 177.
22. Deb, L., Laishram, S., Khumukcham, N., Ningthoukhongjam, D., Nameirakpam, S. S., Dey, A., …
& Ningthoukhongjam, T. R. (2015). Past, present and perspectives of Manipur traditional medi-
cine: A major health care system available for rural population in the North- East India. Journal of
Ethnopharmacology, 169, 387– 400.
23. Che, C. T., George, V., Ijinu, T. P., Pushpangadan, P., & Andrae- Marobela, K. (2017). Traditional
medicine. In Pharmacognosy (pp. 15– 30). Academic Press.
24. Bharate, S. S., Mignani, S., & Vishwakarma, R. A. (2018). Why are the majority of active compounds
in the CNS domain natural products? A critical analysis. Journal of Medicinal Chemistry, 61(23),
10345– 10374.
25. Lin, S. X., Curtis, M. A., & Sperry, J. (2020). Pyridine alkaloids with activity in the central nervous
system. Bioorganic & Medicinal Chemistry, 28(24), 115820.
26. Dey, A., Nanda, B., Nandy, S., Mukherjee, A., & Pandey, D. K. (2020). Implications of phytochemicals
as disease- modifying agents against Huntington’s disease (HD): Bioactivity, animal models and
transgenics, synergism and structure- activity studies. Studies in Natural Products Chemistry,
67, 27– 79.
255
Plant Phytochemicals as Therapeutics in Neurological Disorders
27. Casciaro, B., Mangiardi, L., Cappiello, F., Romeo, I., Loffredo, M. R., Iazzetti, A., & Quaglio, D.
(2020). Infections. Molecules, 25(16), 3619.
28.
Pharmacological Research, 155,
104723.
29. Lichman, B. R. (2021). The scaffold- forming steps of plant alkaloid biosynthesis. Natural Product
Reports, 38(1), 103– 129.
30. Aryal, B., Raut, B. K., Bhattarai, S., Bhandari, S., Tandan, P., Gyawali, K., & Parajuli, N.
neurodegenerative diseases. Evidence- Based Complementary and Alternative Medicine, 2022.
31. Cushnie, T. T., Cushnie, B., & Lamb, A. J. (2014). Alkaloids: An overview of their antibacterial,
antibiotic- enhancing and antivirulence activities. International Journal of Antimicrobial Agents,
44(5), 377– 386.
32. Ain, Q. U., Khan, H., Mubarak, M. S., & Pervaiz, A. (2016). Plant alkaloids as antiplatelet
agent: Drugs of the future in the light of recent developments. Frontiers in Pharmacology, 7, 292.
33. Thawabteh, A., Juma, S., Bader, M., Karaman, D., Scrano, L., Bufo, S. A., & Karaman, R. (2019).
The biological activity of natural alkaloids against herbivores, cancerous cells and pathogens. Toxins,
11(11), 656.
34. Minatel, I. O., Borges, C. V., Ferreira, M. I., Gomez, H. A. G., Chen, C. Y. O., & Lima, G. P. P. (2017).
Phenolic compounds: Functional properties, impact of processing and bioavailability. Phenolic
Compd. Biol. Act, 8, 1– 24.
35. Al Jitan, S., Alkhoori, S. A., & Yousef, L. F. (2018). Phenolic acids from plants: Extraction and appli-
cation to human health. Studies in Natural Products Chemistry, 58, 389– 417.
36. Shahidi, F., & Ambigaipalan, P. (2015). Phenolics and polyphenolics in foods, beverages and
spices: Antioxidant activity and health effects– A review. Journal of Functional Foods, 18, 820– 897.
37. Giada, M. D. L. R. (2013). Food Phenolic Compounds: Main Classes, Sources and Their Antioxidant
Power. Oxidative stress and chronic degenerative diseases- A role for antioxidants, 2013, 87– 112.
38. Gharaati Jahromi, S. (2019). Extraction Techniques of Phenolic Compounds from Plants. IntechOpen.
doi: 10.5772/ intechopen.84705
39. Mathew, S., Abraham, T. E., & Zakaria, Z. A. (2015). Reactivity of phenolic compounds towards free
radicals under in vitro conditions. Journal of Food Science and Technology, 52(9), 5790– 5798.
40. Ambriz- Pérez, D. L., Leyva- López, N., Gutierrez- Grijalva, E. P., & Heredia, J. B. (2016). Phenolic
Cogent Food & Agriculture,
2(1), 1131412.
41. Ambriz- Pérez, D. L., Leyva- López, N., Gutierrez- Grijalva, E. P., & Heredia, J. B. (2016). Phenolic
Cogent Food & Agriculture,
2(1), 1131412.
42. Roleira, F. M., Tavares- da- Silva, E. J., Varela, C. L., Costa, S. C., Silva, T., Garrido, J., & Borges, F.
(2015). Plant- derived and dietary phenolic antioxidants: Anticancer properties. Food Chemistry, 183,
235– 258.
43. Tungmunnithum, D., Thongboonyou, A., Pholboon, A., & Yangsabai, A. (2018). Flavonoids and
other phenolic compounds from medicinal plants for pharmaceutical and medical aspects: An over-
view. Medicines, 5(3), 93.
44. Walsh, D. J., Livinghouse, T., Goeres, D. M., Mettler, M., & Stewart, P. S. (2019). Antimicrobial
Frontiers in Chemistry, 7, 653.
45. Prabhakar, P., & Banerjee, M. (2020). Antidiabetic phytochemicals: a comprehensive review on
opportunities and challenges in targeted therapy for herbal drug development. International Journal
of Pharmaceutical Research, 12, 1673– 1696.
46. Caruso, G., Godos, J., Privitera, A., Lanza, G., Castellano, S., Chillemi, A., & Grosso, G. (2022).
Phenolic acids and prevention of cognitive decline: Polyphenols with a neuroprotective role in cog-
nitive disorders and Alzheimer’s disease. Nutrients, 14(4), 819.
47. Pandey, K. B., & Rizvi, S. I. (2009). Plant polyphenols as dietary antioxidants in human health and
disease. Oxidative Medicine and Cellular Longevity, 2(5), 270– 278.
256
Plant-based Foods and their Implications in Brain Health
48. Shahidi, F., & Ambigaipalan, P. (2015). Phenolics and polyphenolics in foods, beverages and
spices: Antioxidant activity and health effects– A review. Journal of Functional Foods, 18, 820– 897.
49. Singh, B., & Sharma, R. A. (2015). Plant terpenes: defense responses, phylogenetic analysis, regula-
tion and clinical applications. 3 Biotech, 5(2), 129– 151.
50. Perveen, S. (2018). Introductory Chapter: Terpenes and Terpenoids. In S. Perveen, & A. Al- Taweel
(Eds.), Terpenes and Terpenoids. IntechOpen. https:// doi.org/ 10.5772/ int echo pen.79683 .
51. Al Hoqani, U., Leon, R., & Purton, S. (2022). Over- expression of a cyanobacterial gene for 1- deoxy-
D- xylulose- 5- phosphate synthase in the chloroplast of Chlamydomonas reinhardtii perturbs chloro-
phyll: carotenoid ratios. Journal of King Saud University- Science, 102141.
52. Dash, D. K., Tyagi, C. K., Sahu, A. K., & Tripathi, V. (2022). Revisiting the Medicinal Value of
Terpenes and Terpenoids. In V. S. Meena, H. P. Parewa, & S. K. Meena (Eds.), Revisiting Plant
Biostimulants. IntechOpen. https:// doi.org/ 10.5772/ int echo pen.102 612.
53.
Open Chemistry, 15(1), 332– 343.
54. Guimarães, A. C., Meireles, L. M., Lemos, M. F., Guimarães, M. C. C., Endringer, D. C., Fronza,
M., & Scherer, R. (2019). Antibacterial activity of terpenes and terpenoids present in essential oils.
Molecules, 24(13), 2471.
55. Fernandez, L. R., Butassi, E., Svetaz, L., Zacchino, S. A., Palermo, J. A., & Sanchez, M. (2014).
Antifungal Terpenoids from Hyalis argentea var. latisquama. Journal of Natural Products, 77(7),
1579– 1585.
56. Yang, J., Fu, X., Liao, X., & Li, Y. (2020). Nrf2 activators as dietary phytochemicals against oxida-
review. Frontiers in Psychiatry, 11, 561998.
57. Smitha Grace, S. R., Chandran, G., & Chauhan, J. B. (2019). Terpenoids: an activator of “fuel-
sensing enzyme AMPK” with special emphasis on antidiabetic activity. Plant and Human Health,
Volume 2, 227– 244.
58. Asian Journal of
Pharmaceutical and Clinical Research, 10(3), 68– 76.
59. Phulara, S. C., Rajput, V. S., Mazumdar, B., & Runthala, A. (2020). Metabolic and enzyme engin-
eering for the microbial production of anticancer terpenoids. In Essentials of Cancer Genomic,
Computational Approaches and Precision Medicine (pp. 237– 259). Springer, Singapore.
60. Xu, P., & Yu, B. (2021). Chemical synthesis of saponins: An update. In Advances in Carbohydrate
Chemistry and Biochemistry (Vol. 79, pp. 1– 62). Academic Press.
61. Lu, Y. A. O., Jun, L. U., Juan, W. A. N. G., & Wen- Yuan, G. A. O. (2020). Advances in biosynthesis
of triterpenoid saponins in medicinal plants. Chinese Journal of Natural Medicines, 18(6), 417– 424.
62. Juang, Y. P., & Liang, P. H. (2020). Biological and pharmacological effects of synthetic saponins.
Molecules, 25(21), 4974.
63. Moses, T., Papadopoulou, K. K., & Osbourn, A. (2014). Metabolic and functional diversity of
saponins, biosynthetic intermediates and semi- synthetic derivatives. Critical Reviews In Biochemistry
and Molecular Biology, 49(6), 439– 462.
64. Shahzad, N., Khan, W., Shadab, M. D., Ali, A., Saluja, S. S., Sharma, S., & Al- Ghamdi, S. S. (2017).
Phytosterols as a natural anticancer agent: Current status and future perspective. Biomedicine &
Pharmacotherapy, 88, 786– 794.
65. Sharma, N., Tan, M. A., & An, S. S. A. (2021). Phytosterols: Potential metabolic modulators in
neurodegenerative diseases. International Journal of Molecular Sciences, 22(22), 12255.
66. Du, J., Jiang, L., Chen, F., Hu, H., & Zhou, M. (2021). Cardiac glycoside ouabain exerts anticancer
activity via downregulation of STAT3. Frontiers in Oncology, 11, 2565.
67. Prassas, I., & Diamandis, E. P. (2008). Novel therapeutic applications of cardiac glycosides. Nature
Reviews Drug Discovery, 7(11), 926– 935.
68. Kumavath, R., Paul, S., Pavithran, H., Paul, M. K., Ghosh, P., Barh, D., & Azevedo, V. (2021).
Emergence of cardiac glycosides as potential drugs: Current and future scope for cancer therapeutics.
Biomolecules, 11(9), 1275.
69. Abubakar, A. R., & Haque, M. (2020). Preparation of medicinal plants: Basic extraction and fraction-
ation procedures for experimental purposes. Journal of Pharmacy & Bioallied Sciences, 12(1), 1.
257
Plant Phytochemicals as Therapeutics in Neurological Disorders
70. Azwanida, N. N. (2015). A review on the extraction methods used in medicinal plants, principle,
strength and limitation. Med Aromat Plants, 4(196), 2167– 0412.
71. Sasidharan, S., Chen, Y., Saravanan, D., Sundram, K. M., & Latha, L. Y. (2011). Extraction, isolation
and characterization of bioactive compounds from plants’ extracts. African Journal of Traditional,
Complementary and Alternative Medicines, 8(1).
72. Ntalikwa, J. W. (2021). Solvent extraction of jatropha oil for biodiesel production: effects of solvent-
to- solid ratio, particle size, type of solvent, extraction time, and temperature on oil yield. Journal of
Renewable Energy, 2021.
73. Pandey, R. K., Shukla, S. S., Vyas, A., Jain, V., Jain, P., & Saraf, S. (2018). Fingerprinting Analysis
and Quality Control Methods of Herbal Medicines. CRC Press.
74. Pandey, A., & Tripathi, S. (2014). Concept of standardization, extraction and pre phytochemical
screening strategies for herbal drug. Journal of Pharmacognosy and Phytochemistry, 2(5).
75. Suna, S., Tamer, C. E., & Özcan- Sinir, G. (2019). Trends and possibilities of the usage of medicinal
herbal extracts in beverage production. In Natural Beverages (pp. 361– 398). Academic Press.
76. Handa, S. S. (2008). An overview of extraction techniques for medicinal and aromatic plants.
Extraction Technologies for Medicinal and Aromatic Plants, 1, 21– 40.
77. Saifullah, M., McCullum, R., & Vuong, Q. V. (2021). Optimization of microwave- assisted extraction
of polyphenols from Lemon Myrtle: Comparison of modern and conventional extraction techniques
based on bioactivity and total polyphenols in dry extracts. Processes, 9(12), 2212.
78. Mirzadeh, M., Arianejad, M. R., & Khedmat, L. (2020). Antioxidant, antiradical, and antimicro-
bial activities of polysaccharides obtained by microwave- assisted extraction method: A review.
Carbohydrate Polymers, 229, 115421
79. Garcia- Vaquero, M., Ummat, V., Tiwari, B., & Rajauria, G. (2020). Exploring ultrasound, micro-
wave, and ultrasound– microwave assisted extraction technologies to increase the extraction of bio-
active compounds and antioxidants from brown macroalgae. Marine Drugs, 18(3), 172.
80. Dzah, C. S., Duan, Y., Zhang, H., Wen, C., Zhang, J., Chen, G., & Ma, H. (2020). The effects of
ultrasound- assisted extraction on yield, antioxidant, anticancer and antimicrobial activity of poly-
phenol extracts: A review. Food Bioscience, 35, 100547.
81. Raj, G. B., & Dash, K. K. (2020). Ultrasound- assisted extraction of phytocompounds from dragon
fruit peel: Optimization, kinetics and thermodynamic studies. Ultrasonics Sonochemistry, 68,
105180.
82. Kumar, A., Rout, R. K., Rao, P. S., & Prabhakar, P. (2022). Optimization of pulsed mode sonic-
ation and in silico molecular docking study for antioxidant properties of mandarin (Citrus reticulata
Blanco) peels. Journal of Food Process Engineering, e14111.
83. Singh, S., Verma, D. K., Thakur, M., Tripathy, S., Patel, A. R., Shah, N., & Aguilar, C. N. (2021).
algae, its potential trends in food and human health. Food Research International, 150, 110746.
84.
oils– A short review of current trends. Trends in Food Science & Technology, 111 , 249– 260.
85. Swami, H. S., Singh, K. S. P., Gennaro, L., & Dutt, R. D. (2008). Extraction technologies for medi-
cinal and aromatic plants. Trieste: United Nations Industrial Development Organization and the
International Centre for Science and High Technology, 200, 266.
86. Doughari, J. H. (2012). Phytochemicals: Extraction Methods, Basic Structures and Mode of Action
as Potential Chemotherapeutic Agents (pp. 1– 33). Rijeka, Croatia: INTECH Open Access Publisher.
87. Altemimi, A., Lakhssassi, N., Baharlouei, A., Watson, D. G., & Lightfoot, D. A. (2017).
Plants, 6(4), 42.
88. Ingle, K. P., Deshmukh, A. G., Padole, D. A., Dudhare, M. S., Moharil, M. P., & Khelurkar, V. C.
from plant extracts. Journal of Pharmacognosy and Phytochemistry, 6(1), 32– 36.
89. Thakur, A. K., Kamboj, P., Goswami, K., & Ahuja, K. (2018). Pathophysiology and management of
Alzheimer’s disease: An overview. Journal of Analytical & Pharmaceutical Research, 7(1).
90. Lai Shi Min, S., Liew, S. Y., Chear, N. J. Y., Goh, B. H., Tan, W. N., & Khaw, K. Y. (2022). Plant
Terpenoids as the Promising Source of Cholinesterase Inhibitors for Anti- AD Therapy. Biology,
11(2), 307.
258
Plant-based Foods and their Implications in Brain Health
91.
berberine and in vitro evidence for Alzheimer’s disease therapy. Natural Product Communications,
6(8), 1934578X1100600809.
92. Fadaeinasab, M., Basiri, A., Kia, Y., Karimian, H., Ali, H. M., & Murugaiyah, V. (2015). New indole
Cellular
Physiology and Biochemistry, 37(5), 1997– 2011.
93. Yang, Y., Cheng, X., Liu, W., Chou, G., Wang, Z., & Wang, C. (2015). Potent AChE and BChE
inhibitors isolated from seeds of Peganum harmala Linn by a bioassay- guided fractionation. Journal
of Ethnopharmacology, 168, 279– 286.
94. Konrath, E. L., Passos, C. D. S., Klein- Júnior, L. C., & Henriques, A. T. (2013). Alkaloids as a
source of potential anticholinesterase inhibitors for the treatment of Alzheimer’s disease. Journal of
Pharmacy and Pharmacology, 65(12), 1701– 1725.
95. Stavrakov, G., Philipova, I., Lukarski, A., Atanasova, M., Zheleva, D., Zhivkova, Z. D., &
Doytchinova, I. (2020). Galantamine- curcumin hybrids as dual- site binding acetylcholinesterase
inhibitors. Molecules, 25(15), 3341.
96. Ademosun, A. O., Oboh, G., Bello, F., & Ayeni, P. O. (2016). Antioxidative properties and effect
of quercetin and its glycosylated form (Rutin) on acetylcholinesterase and butyrylcholinesterase
activities. Journal of Evidence- Based Complementary & Alternative Medicine, 21(4),
NP11– NP17.
97. Chen, X., & Pan, W. (2014). The treatment strategies for neurodegenerative diseases by integrative
medicine. Integrative Medicine International, 1(4), 223– 225.
98. Pan, L. F., Wang, X. B., Xie, S. S., Li, S. Y., & Kong, L. Y. (2014). Multitarget- directed resveratrol
properties against Alzheimer’s disease. MedChemComm, 5(5), 609– 616.
99.
and antidiabetic activities of three curcuminoids isolated from Curcuma longa L. Natural Product
Research, 31(24), 2914– 2917.
100. Abdel Bar, F. M., Salkini, A. A., Amen, Y., & Sherif, A. E. (2022). Acetylcholinesterase inhibitors
from Conocarpus lancifolius Engl.(Combretaceae). Natural Product Research, 1– 6.
101. Ghafary, S., Ghobadian, R., Mahdavi, M., Nadri, H., Moradi, A., Akbarzadeh, T., & Amini, M.
(2020). Design, synthesis, and evaluation of novel cinnamic acid- tryptamine hybrid for inhibition of
acetylcholinesterase and butyrylcholinesterase. DARU Journal of Pharmaceutical Sciences, 28(2),
463– 477.
102. Aluko, R. E. (2021). Food-derived acetylcholinesterase inhibitors as potential agents against
Alzheimer’s Disease. eFood, 2(2), 49– 58.
103. Murata, T., Selenge, E., Oikawa, S., Ageishi, K., Batkhuu, J., Sasaki, K., & Yoshizaki, F. (2015).
Cholinesterase- inhibitory diterpenoids and chemical constituents from aerial parts of Caryopteris
mongolica. Journal of Natural Medicines, 69(4), 471– 478.
104.
J. P., … & Orhan, I. E. (2017). Selective in vitro and in silico butyrylcholinesterase inhibitory activity
of diterpenes and rosmarinic acid isolated from Perovskia atriplicifolia Benth. and Salvia glutinosa L.
Phytochemistry, 133, 33– 44.
105. Liu, Y., Li, J., Li, D., Li, X. M., Li, D., Zhou, G., & Tan, G. S. (2019). Anti- cholinesterase activities
of constituents isolated from Lycopodiastrum casuarinoides. Fitoterapia, 139, 104366.
106. Chear, N. J. Y., Khaw, K. Y., Murugaiyah, V., & Lai, C. S. (2016). Cholinesterase inhibitory activity
and chemical constituents of Stenochlaena palustris fronds at two different stages of maturity. Journal
of Food and Drug Analysis, 24(2), 358– 366.
107. Fattorusso, A., Di Genova, L., Dell’Isola, G. B., Mencaroni, E., & Esposito, S. (2019). Autism spec-
trum disorders and the gut microbiota. Nutrients, 11(3), 521.
108. Lord, C., Elsabbagh, M., Baird, G., & Veenstra- Vanderweele, J. (2018). Autism spectrum disorder.
The Lancet, 392(10146), 508– 520.
109. Wang, W., Zhang, Y., Jin, W., Xing, Y., & Yang, A. (2018). Catechin weakens diabetic retinopathy
Annals of
Clinical & Laboratory Science, 48(5), 594– 600.
259
Plant Phytochemicals as Therapeutics in Neurological Disorders
110. Zhao, H., Eguchi, S., Alam, A., & Ma, D. (2017). The role of nuclear factor- erythroid 2 related factor
2 (Nrf- 2) in the protection against lung injury. American Journal of Physiology- Lung Cellular and
Molecular Physiology, 312(2), L155– L162.
111. Saha, S., Buttari, B., Panieri, E., Profumo, E., & Saso, L. (2020). An overview of Nrf2 signaling
Molecules, 25(22), 5474.
112. Zgorzynska, E., Dziedzic, B., & Walczewska, A. (2021). An overview of the nrf2/ are pathway and its
role in neurodegenerative diseases. International Journal of Molecular Sciences, 22(17), 9592.
113. Schrier, M. S., Zhang, Y., Trivedi, M. S., & Deth, R. C. (2022). Decreased cortical Nrf2 gene expres-
sion in autism and its relationship to thiol and cobalamin status. Biochimie, 192, 1– 12.
114. Alvarez- Arellano, L., Salazar- García, M., & Corona, J. C. (2020). Neuroprotective effects of quer-
cetin in pediatric neurological diseases. Molecules, 25(23), 5597.
115. Wang, K., Chen, Z., Huang, L., Meng, B., Zhou, X., Wen, X., & Ren, D. (2017). Naringenin reduces
oxidative stress and improves mitochondrial dysfunction via activation of the Nrf2/ ARE signaling
pathway in neurons. International Journal of Molecular Medicine, 40(5), 1582– 1590.
116.
mental paradigm of autism spectrum disorders. Life Sciences, 141, 156– 169.
117. Bhandari, R., Paliwal, J. K., & Kuhad, A. (2020). Dietary phytochemicals as neurotherapeutics for
autism spectrum disorder: plausible mechanism and evidence. Personalized Food Intervention and
Therapy for Autism Spectrum Disorder Management, 615– 646.
118. DeMaagd, G., & Philip, A. (2015). Parkinson’s disease and its management: part 1: disease entity,
risk factors, pathophysiology, clinical presentation, and diagnosis. Pharmacy and Therapeutics,
40(8), 504.
119. Oertel, W. H. (2017). Recent advances in treating Parkinson’s disease. F1000Research, 6.
120. Schneider Medeiros, M., P Reddy, S., P Socal, M., Schumacher- Schuh, A. F., & Mello Rieder, C. R.
(2020). Occupational pesticide exposure and the risk of death in patients with Parkinson’s disease: an
observational study in southern Brazil. Environmental Health, 19(1), 1– 8.
121. Calderón- Garcidueñas, L. (2021). Parkinson disease and air pollution: does what we breathe matter?.
Nature Reviews Neurology, 17(8), 467– 468.
122. de Oliveira, G. A., & Silva, J. L. (2019). Alpha- synuclein stepwise aggregation reveals features of an
early onset mutation in Parkinson’s disease. Communications Biology, 2(1), 1– 13.
123. Meade, R. M., Fairlie, D. P., & Mason, J. M. (2019). Alpha- synuclein structure and Parkinson’s
disease– lessons and emerging principles. Molecular Neurodegeneration, 14(1), 1– 14.
124. Meade, R. M., Fairlie, D. P., & Mason, J. M. (2019). Alpha- synuclein structure and Parkinson’s
disease– lessons and emerging principles. Molecular Neurodegeneration, 14(1), 1– 14.
125. Wang, Y., Shi, M., Chung, K. A., Zabetian, C. P., Leverenz, J. B., Berg, D., … & Zhang, J. (2012).
Science Translational Medicine, 4(121),
121ra20– 121ra20.
126. Shahpiri, Z., Bahramsoltani, R., Farzaei, M. H., Farzaei, F., & Rahimi, R. (2016). Phytochemicals as
future drugs for Parkinson’s disease: a comprehensive review. Reviews in the Neurosciences, 27(6),
651– 668.
127. Lei, P., Ayton, S., & Bush, A. I. (2021). The essential elements of Alzheimer’s disease. Journal of
Biological Chemistry, 296.
128.
Biochimica et Biophysica Acta (BBA)- General Subjects, 1830(4), 2872– 2881.
129.
Neuroscience Letters, 655, 109– 114.
130. Jha, N. N., Kumar, R., Panigrahi, R., Navalkar, A., Ghosh, D., Sahay, S., & Maji, S. K. (2017).
ACS Chemical
Neuroscience, 8(12), 2722– 2733.
131. Fu, G., Zhang, W., Du, D., Ng, Y. P., Ip, F. C., Tong, R., & Ip, N. Y. (2017). Diarylheptanoids from
Journal of Agricultural and
Food Chemistry, 65(31), 6608– 6614.
260
Plant-based Foods and their Implications in Brain Health
132. Ghanem, S. S., Fayed, H. S., Zhu, Q., Lu, J. H., Vaikath, N. N., Ponraj, J., & El- Agnaf, O. M. (2021).
Molecules, 26(12), 3736.
133.
terpenoids from Abrus precatorius against Parkinson’s disease proteins using in silico approach.
Bioinformatics and Biology Insights, 15, 11779322211050757.
134. Mestre, T. A., & Sampaio, C. (2017). Huntington disease: linking pathogenesis to the development of
experimental therapeutics. Current Neurology and Neuroscience Reports, 17(2), 1– 8.
135. Reilmann, R. (2013). Pharmacological treatment of chorea in Huntington’s disease– good clinical
practice versus evidence-based guideline. Movement Disorders, 28(8), 1030– 1033.
136. Hsu, Y. T., Chang, Y. G., & Chern, Y. (2018). Insights into GABAAergic system alteration in
Huntington’s disease. Royal Society, Open Biology, 8(12), 180165.
137. Halliwell, B. (2007). Oxidative stress and cancer: have we moved forward? Biochemical Journal,
401(1), 1– 11
138. Schramm, A., Ebrahimi, S. N., Raith, M., Zaugg, J., Rueda, D. C., Hering, S., & Hamburger, M.
labdane diterpenoids as positive GABAA receptor modulators. Phytochemistry, 96, 318– 329.
139. Moniruzzaman, M., Mannan, M. A., Hossen Khan, M. F., Abir, A. B., & Afroze, M. (2018). The
leaves of Crataeva nurvala Buch- Ham. modulate locomotor and anxiety behaviors possibly through
GABAergic system. BMC Complementary and Alternative Medicine, 18(1), 1– 12.
140. Dey, P., Kundu, A., Kumar, A., Gupta, M., Lee, B. M., Bhakta, T., & Kim, H. S. (2020). Analysis of
alkaloids (indole alkaloids, isoquinoline alkaloids, tropane alkaloids). In Recent Advances in Natural
Products Analysis (pp. 505– 567). Elsevier.
141. Crunkhorn, S. (2012). Nanoparticle opens door to cerebral palsy treatment. Nature Reviews Drug
Discovery, 11(6), 440– 440.
142.
ural products in attenuation of Alzheimer’s disease. Frontiers in Pharmacology, 9, 548.
143.
Alkaloids from Ailanthus altissima. Planta Medica, 50(08), 527– 535.
144. Gao, P., Wang, L., Zhao, L., Zhang, Q. Y., Zeng, K. W., Zhao, M. B., & Guo, X. Y. (2020). Anti-
Phytochemistry, 172,
112260.
145.
pathway by resveratrol improves spinal cord injury. Frontiers in Neuroscience, 12, 690.
146. Lai, W. W., Hsu, S. C., Chueh, F. S., Chen, Y. Y., Yang, J. S., Lin, J. P., & Chung, J. G. (2013).
Quercetin inhibits migration and invasion of SAS human oral cancer cells through inhibition
Anticancer Research, 33(5),
1941– 1950.
147. Chang, X., He, H., Zhu, L., Gao, J., Wei, T., Ma, Z., & Yan, T. (2015). Protective effect of apigenin on
Chemical-
biological Interactions, 236, 41– 46.
148. Wang, W., Zhang, Y., Jin, W., Xing, Y., & Yang, A. (2018). Catechin weakens diabetic retinopathy
Annals of
Clinical & Laboratory Science, 48(5), 594– 600.
149. Kambli, L., Bhatt, L. K., Oza, M., & Prabhavalkar, K. (2017). Novel therapeutic targets for epilepsy
intervention. Seizure, 51, 27– 34.
150. Aliyu, M. M., Musa, A. I. I., Kamal, M. J. A., & Mohammed, M. G. (2014). Phytochemical screening
and anticonvulsant studies of ethyl acetate fraction of Globimetula braunii on laboratory animals.
Asian Pacic Journal of Tropical Biomedicine, 4(4), 285– 289.
151. Aghdash, S. N. (2021). Herbal medicine in the treatment of epilepsy. Current Drug Targets, 22(3),
356– 367.
152. Zhang, H., & Tsao, R. (2016). Dietary polyphenols, oxidative stress and antioxidant and anti-
Current Opinion in Food Science, 8, 33– 42.
153.
pathogenesis: Role of polyphenols. Biomedicine & Pharmacotherapy, 129, 110452.
261
Plant Phytochemicals as Therapeutics in Neurological Disorders
154.
Food
Chemistry, 344, 128660.
155. Gabay, O., Sanchez, C., Salvat, C., Chevy, F., Breton, M., Nourissat, G., & Berenbaum, F. (2010).
Stigmasterol: a phytosterol with potential anti- osteoarthritic properties. Osteoarthritis and Cartilage,
18(1), 106– 116.
156. Jung, H. Y., Nam, K. N., Woo, B. C., Kim, K. P., Kim, S. O., & Lee, E. H. (2013). Hirsutine, an
-
glial activation. Molecular Medicine Reports, 7(1), 154– 158.
157.
cytokine- induced IL- 6 and CCL11 production via modulation of STAT6 pathway in human bron-
chial epithelial cells. International Journal of Medical Sciences, 17(10), 1464.
262
DOI: 10.1201/9781003300502-13
13
Phytoconstituents
The Natural Tonic for a
Healthy Brain
Bapi Ray Sarkar, Simran Giri, Ganesh Dey,
and Prosanta Pal
13.1 INTRODUCTION
In the 18th century, William James recognized that one of the most important characteristics of
humans is the ability to change their behaviour in response to their surroundings. The concept
of plasticity has since been expanded to include changes underlying the structure of the brain
at various levels, ranging from cellular to systematic, with the intermingling of these changes
aiding the phenomenon of behavioural plasticity [1]. Since then, it has been clear that the brain is
the vital organ for the coordination and multifunctioning of the body. In the year 1948, according
healthy brain because it is the brain that is responsible for all actions [2
ition of a healthy brain is still controversial in many aspects, different health authorities, like the
-
form all of the psychological processes, including perception, as well as counting the capacity
to learn and pass judgement, use language, and recall it [3]. According to the American Heart
performance levels among all people at that age who are free of known brain or other organ
system diseases in terms of decline from function levels, or as adequacy to perform all activ-
ities that the individual wishes to undertake’ [4]. The online survey was conducted for the very
led in collaboration with Sweden, the National University of Ostroh Academy, national brain
councils in Norway, Germany, and Belgium, the Women’s Brain Project, and Brain Foundations
in the Netherlands, where the condition of brain health is analysed in 14 different languages in
groups of people, at least at the expense and, from the result of a survey, a bit of knowledge
regarding the perspectives on the brain’s health. The degree of reception of positive practices
can be empowered. The outcomes add to the advancement of strategy suggestions for supporting
population brain health, including measures custom- made to individual requirements, informa-
tion, inspirations, and life circumstances [5].
For many decades, natural products, including plant and animal products, were used to make drugs.
Largely from the plant source, drugs were made because it was found that the plant produces plenty
of different structured organic compounds (phytoconstituents), which are often called secondary
263
Phytoconstituents: The Natural Tonic for a Healthy Brain
become simpler. Hence, the structure of phytoconstituents was easily characterized and many of
them are synthetically made in laboratories nowadays. With the advancement in technology, the
6]. Regardless of
sources for screening drug discovery. This has been a result of the drawbacks of natural products
like trouble in supply, complex chemical constituents, and intrinsically slow working patterns
with natural sources as well as worries about intellectual property rights. There is quite a large
number of promising medication applicants in the current advancement pipeline that are of natural
source. Specialized disadvantages related to natural item research have been reduced, and there
are more chances to investigate the pharmacological activity of unexplored natural sources. By
understanding and accepting the complexity of chemical compounds from natural sources, it is
found that natural products are appropriate to give the centre platforms for future medications and
advancements in the utilization of novel natural sources [7]. It is assumed that the risk connected
with herbal products is minimal. Even though the number of adverse reactions to herbal medication
is quite low, somehow, the reports of reactions point to the need for marker systems that are excel-
herbal medicinal components, marker- based standards are becoming increasingly common. Herbal
medicines, on the other hand, are made from the extract of plants and require a multi- marker system
to be implemented. The impact of storage conditions is a crucial consideration. A pharmacopeial
comparison of standards, in general, demonstrates that there are a lot of variances in plant types,
metals, and microbial contamination in many nations. Hence, standards that are peculiar to each
country, as well as regional guidelines, have been developed, and only a few of them are accepted at
this time [8]. In this chapter, things will be clearer about growing natural product use, and its effect
on brain health.
13.2 TRADITIONAL PREPARATIONS AND FORMULATIONS
Medicinal herbs are potential sources of therapeutic aids. Natural products from natural origin (plant,
animal, and minerals) have not been used only on the basis of the treatment of disease but also play
an important role in the development and function of humans and animals. Tribal healers in most of
the countries are using various health tonics along with various formulations to treat diseases [9].
A healthy diet is the most important part of a mother during her pregnancy for the function and
development of her child. It is important that all necessary energy and nutrients are absorbed from
the diet during the development of brain structures [10]. At the fetal brain development stage, a
transduction. At the age of one or two years, neurons and neuronal connections are produced at
peak levels [11]. During gestation and early childhood, malnutrition induces the development of
tryptophan and tyrosine are the precursors of serotonin, dopamine, and norepinephrine, respectively
[12]. Tyrosine supplementation also enhances the cognitive performance of the brain [13]. Brain
foods also help to optimize mental performance [14]. Micronutrients, vitamins, and trace elements
are essential during early brain development [15]. Several micronutrients, vitamins, and related trace
elements, including folate, vitamin B12, and choline, are related to homocysteine concentrations,
providing a link to 1- carbon metabolism, biosynthesis of phospholipids, and DNA methylation,
which are involved in brain development [16].
A lot of preparations or formulations have been used since ancient times for the purpose
selecting food supplements at that time. The commonly used preparation and formulations are
as follows: